These modules were associated with age, sex, and race, as well as core AD biomarkers, including Aβ, tau, and phosphorylated tau (p‐tau), highlighting interactions between diagnostic or progressive AD biomarkers and an individual's demographic background. This evidence concerns the gene MAPT and Alzheimer disease.